Latest & greatest articles for HIV Test

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on HIV Test or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on HIV Test and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for HIV Test

81. Pathology test to determine if a patient has been infected with CCR5 tropic HIV-1 for access to maraviroc

patient population for genotypic tropism testing – to distinguish between HIV which has the co-receptor to the CD4 receptor solely in the CCR5 state (R5-tropism) or has some of this co-receptor in the CXCR4 state (X4-tropism) – would have human immunodeficiency virus (HIV-1) infection, and that there was no need or basis to enrich this population for testing. MSAC considered that it could not adequately respond to PBAC’s referral for advice on the characteristics and numbers of patients with HIV-1 (...) by the applicant. 2. Background The process of using specific assays to determine the genetic makeup of the HIV virus ahead of making treatment decisions is known as genotype-assisted antiretroviral resistance testing (GART). The overarching aim of GART is to collect patient-level information on the genetic 2 makeup of the infecting HIV type in order to guide treatment approaches that are more likely to reduce viral load in patients than if GART was not performed. In Australia, GART testing is performed

2012 Medical Services Advisory Committee

82. Pathology test to determine if a patient has been infected with CCR5 tropic HIV-1 for access to maraviroc

accurately distinguish between individuals with R5-tropic virus (who will respond to HIV treatment regimens involving maraviroc to the same extent as to these alternative regimens) and individuals with X4-tropic virus (who will have a less effective response to regimens involving maraviroc). Where there are existing anti-retroviral therapy options (that is, the proposed PBS listing of maraviroc), a high level of test accuracy is required because any false positive R5-tropism results will mean (...) Pathology test to determine if a patient has been infected with CCR5 tropic HIV-1 for access to maraviroc Pathology test to determine if a patient has been infected with CCR5 tropic HIV-1 for access to maraviroc Pathology test to determine if a patient has been infected with CCR5 tropic HIV-1 for access to maraviroc Medical Services Advisory Committee Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has

2012 Health Technology Assessment (HTA) Database.

83. Return on public health investment: CDC's expanded HIV testing initiative Full Text available with Trip Pro

Return on public health investment: CDC's expanded HIV testing initiative Return on public health investment: CDC's expanded HIV testing initiative Return on public health investment: CDC's expanded HIV testing initiative Hutchinson AB, Farnham PG, Duffy N, Wolitski RJ, Sansom SL, Dooley SW, Cleveland JC, Mermin JH Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods (...) , the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary The study examined the clinical/economic impact of a large-scale HIV testing programme – the Expanded HIV-Testing Initiative (EHTI) – for populations affected disproportionally by HIV. The economic evaluation was based on a financial return on investment (ROI) analysis. The authors concluded that the programme averted HIV infections and provided positive ROI

2012 NHS Economic Evaluation Database.

84. Rapid HIV Testing in Correctional Facilities

: a gateway to novel research and interven- tions. Journal of correctional health care : the official journal of the National Commission on Correc- tional Health Care. 2011;17(1):69- 76. 7. Macgowan R, Margolis A, Richard- son-Moore A, Wang T, Lalota M, French PT, et al. Voluntary rapid human immunodeficiency virus (HIV) testing in jails. Sexually trans- mitted diseases. 2009;36(2 Suppl):S9-13. 8. Kacanek D, Eldridge GD, Nealey- Moore J, MacGowan RJ, Binson D, Flanigan TP, et al. Young incarcer- ated (...) quality of life and prevent the spread of the virus 7 . The literature indicates a need for more HIV testing in correctional settings. In a 2002 survey, only 21.6% of inmates reported that they received an HIV test after admission 7 . Another study noted that fewer than 5% of correctional facilities offer HIV testing at all 6 . What We Found The literature shows that while prisoners in correctional facilities often welcome HIV testing 8 , the procedure is not consistently available. 6,7 For a 12-month

2012 Ontario HIV Treatment Network

85. Guidance on couples HIV testing and counselling - including antiretroviral therapy for treatment and prevention in serodiscordant couples

Guidance on couples HIV testing and counselling - including antiretroviral therapy for treatment and prevention in serodiscordant couples WHO | Guidance on couples HIV testing and counselling - including antiretroviral therapy for treatment and prevention in serodiscordant couples WHO Regional websites Access HIV/AIDS Menu Guidance on couples HIV testing and counselling - including antiretroviral therapy for treatment and prevention in serodiscordant couples Recommendations for a public health (...) approach Publication details Editors : WHO HIV/AIDS Programme Number of pages : 80 Publication date : April 2012 Languages : English ISBN : 978 92 4 150197 2 Downloads pdf, 727kb Overview New WHO guidelines recommend offering HIV testing and counselling to couples, wherever HIV testing and counselling is available, including in antenatal clinics. For couples where only one partner is HIV positive, the guidelines recommend offering antiretroviral therapy to the HIV positive partner, regardless of his

2012 World Health Organisation Guidelines

86. Guidance on couples HIV testing and counselling - including antiretroviral therapy for treatment and prevention in serodiscordant couples

Behaviour change communication CDC U.S. Centers for Disease Control and Prevention Ch TC Couples HIV testing and counselling Ch W Community health workers CI Confidence interval DALY Disability-adjusted life year Dh S Demographic and Health Surveys GRADE Grading of Recommendations Assessment, Development and Evaluation GRC Guidelines Review Committee h IV Human immunodeficiency virus h TC HIV testing and counselling IDU Injecting drug users IEC Information, education and communication IpV Intimate (...) OF RECOMMENDATIONS 20 2.1 Couples HIV testing and counselling 20 2.2 ART for prevention in serodiscordant couples 24 3. GUIDING pRINCIpLES FOR IMpLEMENTATION 29 3.1 Voluntary utilization of testing services 29 3.2 Five Cs—consent, confidentiality, counselling, correct test results, link to care 29 3.3 Access to justice 30 3.4 Human rights 30 3.5 Provision of earlier treatment 31 4. OpERATIONAL ISSUES FOR IMpLEMENTATION 33 4.1 Overarching issues 33 4.2 Antenatal, perinatal and postnatal care 43 4.3 Other clinical

2012 World Health Organisation HIV Guidelines

87. The cost-effectiveness of introducing nucleic acid testing to test for hepatitis B, hepatitis C, and human immunodeficiency virus among blood donors in Sweden

The cost-effectiveness of introducing nucleic acid testing to test for hepatitis B, hepatitis C, and human immunodeficiency virus among blood donors in Sweden Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2011 NHS Economic Evaluation Database.

88. HIV testing: increasing uptake in men who have sex with men

HIV testing: increasing uptake in men who have sex with men HIV testing: increasing uptake in men who have sex with men | Guidance | NICE HIV testing: increasing uptake in men who have sex with men Public health guideline [PH34] Published date: March 2011 Guidance This guidance has been updated and replaced by . Explore © NICE [year]. All rights reserved. Subject to .

2011 National Institute for Health and Clinical Excellence - Clinical Guidelines

89. HIV testing: increasing uptake in black Africans

HIV testing: increasing uptake in black Africans HIV testing: increasing uptake in black Africans | Guidance | NICE HIV testing: increasing uptake in black Africans Public health guideline [PH33] Published date: March 2011 Guidance This guidance has been updated and replaced by . Explore © NICE [year]. All rights reserved. Subject to .

2011 National Institute for Health and Clinical Excellence - Clinical Guidelines

90. Adolescents and HIV Infection: The Pediatrician's Role in Promoting Routine Testing

, Committee on Adolescence . Adolescents and human immunodeficiency virus infection: the role of the pediatrician in prevention and intervention . 9. Centers for Disease Control and Prevention . HIV/AIDS surveillance in adolescents and young adults (through 2007) . Available at: . Accessed January 14, 2010 10. Hall HI , Song R , Rhodes P , et al. ; HIV Incidence Surveillance Group . Estimation of HIV incidence in the United States . 11. Eaton DK , Kann L , Kinchen S , et al. ; Centers for Disease Control (...) , Cooper E , Flynn P , Futterman DC . Current pediatrician practices in identifying high-risk behaviors of adolescents . Pediatrics . 2010 ; 125 ( 4 ). Available at: 18. Bartlett JG , Branson BM , Fenton K , Hauschild BC , Miller V , Mayer KH . Opt-out testing for human immunodeficiency virus in the United States: progress and challenges . 19. American Academy of Pediatrics . Bright Futures adolescent supplemental questionnaire 15 to 17 year visits . Available at: . Accessed February 2, 2010 20. Elster

2011 American Academy of Pediatrics

91. The cost-effectiveness of symptom-based testing and routine screening for acute HIV infection in men who have sex with men in the USA Full Text available with Trip Pro

The cost-effectiveness of symptom-based testing and routine screening for acute HIV infection in men who have sex with men in the USA The cost-effectiveness of symptom-based testing and routine screening for acute HIV infection in men who have sex with men in the USA The cost-effectiveness of symptom-based testing and routine screening for acute HIV infection in men who have sex with men in the USA Juusola JL, Brandeau ML, Long EF, Owens DK, Bendavid E Record Status This is a critical abstract (...) was effective over 20 years, but the addition of symptom-based viral load testing was more effective and relatively inexpensive. The methods, analyses, and results were mostly clear, and the authors’ conclusions appear to be reasonable. Type of economic evaluation Cost-effectiveness analysis, cost-utility analysis Study objective The aim was to examine the cost-effectiveness of strategies to detect and treat HIV in men who have sex with men. The target population was men aged 13 to 64 years, which

2011 NHS Economic Evaluation Database.

92. Promoting the uptake of HIV testing among men who have sex with men: systematic review of effectiveness and cost-effectiveness

Promoting the uptake of HIV testing among men who have sex with men: systematic review of effectiveness and cost-effectiveness Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2011 DARE.

93. The cost-effectiveness of HIV voluntary counseling and testing in China Full Text available with Trip Pro

and testing in China. Asia-Pacific Journal of Public Health 2011; 23(4): 620-633 PubMedID DOI Original Paper URL Indexing Status Subject indexing assigned by NLM MeSH Adolescent; Adult; Algorithms; China; Cost-Benefit Analysis; Counseling /economics; Female; HIV Infections; HIV Seropositivity /diagnosis; Humans; Male; Mass Screening; Middle Aged; Young Adult AccessionNumber 22012000196 Date bibliographic record published 22/02/2012 Date abstract record published 25/07/2012 NHS Economic Evaluation Database (...) The cost-effectiveness of HIV voluntary counseling and testing in China The cost-effectiveness of HIV voluntary counseling and testing in China The cost-effectiveness of HIV voluntary counseling and testing in China Wang S, Moss JR, Hiller JE Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment

2011 NHS Economic Evaluation Database.

94. HIV screening via fourth-generation immunoassay or nucleic acid amplification test in the United States: a cost-effectiveness analysis Full Text available with Trip Pro

HIV screening via fourth-generation immunoassay or nucleic acid amplification test in the United States: a cost-effectiveness analysis HIV screening via fourth-generation immunoassay or nucleic acid amplification test in the United States: a cost-effectiveness analysis HIV screening via fourth-generation immunoassay or nucleic acid amplification test in the United States: a cost-effectiveness analysis Long EF Record Status This is a critical abstract of an economic evaluation that meets (...) the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary The study assessed the population-based cost-effectiveness of universal or targeted HIV screening with a fourth-generation immunoassay versus screening for acute infection with a pooled nucleic acid amplification test for various screening frequencies and target populations

2011 NHS Economic Evaluation Database.

95. Home-based HIV voluntary counselling and testing (VCT) for improving uptake of HIV testing. Full Text available with Trip Pro

Home-based HIV voluntary counselling and testing (VCT) for improving uptake of HIV testing. The low uptake of HIV voluntary counselling and testing (VCT) has hindered global attempts to prevent new HIV infections and has limited scale-up of HIV care and treatment. Globally, only 10% of HIV-infected individuals are aware of their HIV status. One approach to increase uptake is home-based HIV VCT, which may be effective in increasing the number of patients on treatment and preventing new (...) infections.To establish the effect of home-based HIV VCT on uptake of HIV testingWe searched MEDLINE (February 2007), EMBASE (February 2007), CENTRAL (February 2007), AIDSearch (February 2007), LILACS, CINAHL and Sociofile. We also contacted relevant researchers. The original review search strategy was updated in 2008.Randomised controlled trials comparing home-based HIV VCT with other testing modelsTwo review authors independently selected studies, assessed methodological quality, and extracted data. We

2010 Cochrane

96. Evaluation of an HIV nucleic acid testing program with automated Internet and voicemail systems to deliver results. Full Text available with Trip Pro

Evaluation of an HIV nucleic acid testing program with automated Internet and voicemail systems to deliver results. Nucleic acid testing (NAT) in routine HIV testing programs can increase the detection of infected individuals, but the most effective implementation of NAT remains unclear.To determine how many HIV cases can be identified with NAT and how many persons can be contacted, to identify predictors of acute and early HIV infection cases, and to test reporting of negative results (...) by automated Internet and voicemail systems.Prospective study.San Diego County, California.Persons seeking HIV testing.Rates and predictors of HIV infection by stage, notification of positive NAT results, use of automated Internet or voicemail systems to access negative NAT results, and estimated HIV infections prevented.Of 3151 persons tested, 79 had newly diagnosed cases of HIV: 64 had positive results from rapid HIV test, and 15 had positive results only by NAT (that is, NAT increased the HIV detection

2010 Annals of Internal Medicine

97. WITHDRAWN: Home-based HIV voluntary counseling and testing in developing countries. (Abstract)

WITHDRAWN: Home-based HIV voluntary counseling and testing in developing countries. The low uptake of HIV voluntary counseling and testing (VCT), an effective HIV prevention intervention, has hindered global attempts to prevent new HIV infections, as well as limiting the scale-up of HIV care and treatment for the estimated 38 million infected persons. According to UNAIDS, only 10% of HIV-infected individuals worldwide are aware of their HIV status. At this point in the HIV epidemic, a renewed (...) focus has shifted to prevention, and with it, a focus on methods to increase the uptake of HIV VCT. This review discusses home-based HIV VCT delivery models, which, given the low uptake of facility-based testing models, may be an effective avenue to get more patients on treatment and prevent new infections.(1) To identify and critically appraise studies addressing the implementation of home-based HIV voluntary counseling and testing in developing countries. (2) To determine whether home-based HIV

2010 Cochrane

98. Poor sensitivity of field rapid HIV testing: implications for mother-to-child transmission programme (Abstract)

Poor sensitivity of field rapid HIV testing: implications for mother-to-child transmission programme We validated rapid HIV tests among pregnant women in a clinical setting. Field testing was performed using First Response 1,2,3 or Standard Diagnostic and Pareekshak tests. Results were confirmed by third generation HIV ELISA. Discordant or negative, specimens were confirmed by RNA PCR and a fourth generation ELISA test. Sensitivity and specificity were 94.5% (CI: 85.8-98.2) and 100% for First

2010 EvidenceUpdates

99. The association of HIV susceptibility testing with survival among HIV-infected patients receiving antiretroviral therapy: a cohort study. (Abstract)

The association of HIV susceptibility testing with survival among HIV-infected patients receiving antiretroviral therapy: a cohort study. HIV-1 genotypic and phenotypic susceptibility testing (GPT) optimizes antiretroviral selection, but its effect on survival is unknown.To evaluate the association between GPT and survival.Cohort study.10 U.S. HIV clinics.2699 HIV-infected patients eligible for GPT (plasma HIV RNA level >1000 copies/mL) seen from 1999 through 2005.Demographic characteristics (...) , clinical factors, GPT use, all-cause mortality, and crude and adjusted hazard ratios (HRs) for the association of GPT with survival.Patients were followed for a median of 3.3 years; 915 (34%) had GPT. Patients who had GPT had lower mortality rates than those who did not (2.0 vs. 2.7 deaths per 100 person-years). In standard Cox models, GPT was associated with improved survival (adjusted HR, 0.69 [95% CI, 0.51 to 0.94]; P = 0.017) after controlling for demographic characteristics, CD4+ cell count, HIV

2009 Annals of Internal Medicine

100. Consistency of State Statutes With the Centers for Disease Control and Prevention HIV Testing Recommendations for Health Care Settings. Full Text available with Trip Pro

Consistency of State Statutes With the Centers for Disease Control and Prevention HIV Testing Recommendations for Health Care Settings. In September 2006, the Centers for Disease Control and Prevention (CDC) released the "Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-care Settings" to improve screening and diagnosis. The CDC now recommends that all patients in all health care settings be offered opt-out HIV screening without separate written (...) consent and prevention counseling. State law on HIV testing is widely assumed to be a barrier to implementing the recommendations. To help policymakers and providers better understand their own legal context and to correct possible misunderstandings about statutory compatibility, a state-by-state review (including Washington, DC) of all statutes pertaining to HIV testing was performed and the consistency of these laws with the new recommendations was systematically assessed. Criteria were developed

2009 Annals of Internal Medicine